World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and fatal condition that requires early diagnosis, management, and specific treatment. The availability of new disease-modifying therapies has made successful treatment a reality. Transthyretin amyloid cardiomyopathy can be either age-r...
Príomhchruthaitheoirí: | , , , , , , , , , , , , , , , , , , |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Ubiquity Press
2023-10-01
|
Sraith: | Global Heart |
Ábhair: | |
Rochtain ar líne: | https://account.globalheartjournal.com/index.php/up-j-gh/article/view/1262 |